Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Single-Payer/Medicare-for-All

Saturday Links

Posted on February 18, 2023February 19, 2023 by John C. Goodman
  • The (health ) case against homelessness.
  • Lead poisoning is a worldwide problem.
  • The negative relationship between obesity and income is almost entirely driven by women. The relationship between income and weight is flat for men.
  • Finally the press gets its comeuppance in the Columbia Journalism Review for promoting the Trump-Russia hoax.
  • JAMA study: Medicare Advantage plans have higher quality and lower cost than traditional Medicare.
+

Monday Links

Posted on November 28, 2022 by John C. Goodman
  • Elon Musk threatens to release damning information on Twitter’s internal discussions about the decision to censor the Hunter Biden lap top story.
  • Fauci leaves with no apologies. Here is why apologies are needed.
  • Scott Atlas:  Drs. Anthony Fauci and Deborah Birx, as well as academics who supported lockdown measures, have left behind a harmful legacy that Americans are still grappling with today.
  • New Biden regulations threaten to turn Medicaid into “Welfare for All”.
  • Which is better: Medicare or Medicare Advantage? NYT gives a biased view.
+

Another Argument against Medicare for All

Posted on September 13, 2022 by John C. Goodman

From my latest column at Forbes:

Consider the effect of having one insurer cover drugs, while the other two are covering medical care. If a diabetic skips his insulin and other medications, that is actually profitable for the drug insurer – since these are expenses it doesn’t have to cover. However, if such non-adherence to a drug regimen leads to emergency room visits and hospitalization, those are costs the other two insurers will have to bear.

+

Tuesday Links

Posted on August 9, 2022August 9, 2022 by John C. Goodman
  • What if the FTC truth-in-advertising law applied to Congress? CBO: The inflation Reduction Act will have a negligible effect on inflation.
  • Nurses leaving the ER for Botox.
  • Company wants a cell or two from you, so it can grow an embryo and harvest organs. HT: Tyler  Ghoulish
  • Since Democrats need every vote to pass their IRA bill, their new approach to Covid in Congress is: “Don’t ask, don’t tell.”
  • The controversy over SSRIs has become political. But shouldn’t we all want to know what antidepressants mass shooters were on when they opened up on innocent victims?
+
  • 1
  • 2
  • 3
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 12 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom